✦ LIBER ✦

WS5.2 Inhaled dry powder mannitol in cystic fibrosis (CF): impact on pulmonary exacerbations (PEs) in the Phase III studies (CF-301 & CF-302)

✍ Scribed by D. Bilton; M. Aitken; K. De Boeck; H. Fox; B. Charlton

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

79 Inhaled dry powder mannitol in cystic

✍ D. Bilton; M. Aitken; H. Fox; B. Charlton 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB

301 An analysis of medical resource util

✍ Toward, T.J.; Van Engen, A.; Bilton, D. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 62 KB

77* Phase III Study [CF-302] of inhaled

✍ M. Aitken; P.A. Flume; D.E. Geller; A. Lapey; J. Zuckerman; K. De Boeck; G. Bell 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Randomised, double blind, placebo-contro

✍ D. Bilton; P. Robinson; P. Cooper; B. Charlton 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB

78 Combined data from two phase III stud

✍ D. Bilton; M. Aitken; P.A. Flume; D.E. Geller; A. Lapey; J. Zuckerman; K. De Boe 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 49 KB